335 related articles for article (PubMed ID: 28663063)
1. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
[TBL] [Abstract][Full Text] [Related]
2. Development of a Conceptual Model for the Patient Experience of Focal Segmental Glomerulosclerosis (FSGS): A Qualitative Targeted Literature Review.
Aldhouse NVJ; Kitchen H; Al-Zubeidi T; Thursfield M; Winnette R; See Tai S; Zhu L; Garnier N; Baker CL
Adv Ther; 2023 Dec; 40(12):5155-5167. PubMed ID: 37819555
[TBL] [Abstract][Full Text] [Related]
3. Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
Matza LS; Stewart KD; Naegeli AN; Mills KM; Coyne KS; Chew KW; Hughes MD; Smith DM
J Patient Rep Outcomes; 2023 Jan; 7(1):8. PubMed ID: 36719546
[TBL] [Abstract][Full Text] [Related]
4. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
[TBL] [Abstract][Full Text] [Related]
5. Development and content validity of a hemodialysis symptom patient-reported outcome measure.
Flythe JE; Dorough A; Narendra JH; Wingard RL; Dalrymple LS; DeWalt DA
Qual Life Res; 2019 Jan; 28(1):253-265. PubMed ID: 30229532
[TBL] [Abstract][Full Text] [Related]
6. Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
Bradley H; Trennery C; Jones AM; Lydon A; White F; Williams-Hall R; Arbuckle R; Tomaszewski E; Shih VH; Haughney J; Eisen A; Winders T; Coons SJ; Eremenco S;
J Patient Rep Outcomes; 2023 Oct; 7(1):104. PubMed ID: 37863864
[TBL] [Abstract][Full Text] [Related]
7. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
[TBL] [Abstract][Full Text] [Related]
8. Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures.
Mathias SD; Berry P; De Vries J; Pascoe K; Colwell HH; Chang DJ; Askanase AD
J Patient Rep Outcomes; 2017; 2(1):11. PubMed ID: 29757295
[TBL] [Abstract][Full Text] [Related]
9. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
[TBL] [Abstract][Full Text] [Related]
10. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
Patient; 2013; 6(4):291-305. PubMed ID: 24062234
[TBL] [Abstract][Full Text] [Related]
11. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life in Focal Segmental Glomerular Sclerosis and Minimal Change Disease: A Qualitative Study of Children and Adults to Inform Patient-Reported Outcomes.
Carlozzi NE; Massengill SF; Trachtman H; Walsh L; Singhal N; LaVigne JM; Miner JA; Desmond HE; Lynam C; Gipson DS
Kidney Med; 2021; 3(4):484-497.e1. PubMed ID: 34401716
[TBL] [Abstract][Full Text] [Related]
13. Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.
Dulai PS; Jairath V; Khanna R; Ma C; McCarrier KP; Martin ML; Parker CE; Morris J; Feagan BG; Sandborn WJ
Aliment Pharmacol Ther; 2020 Jun; 51(11):1047-1066. PubMed ID: 32319120
[TBL] [Abstract][Full Text] [Related]
14. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
[TBL] [Abstract][Full Text] [Related]
15. Development of the Multiple Myeloma Symptom and Impact Questionnaire: A New Patient-Reported Outcome Instrument to Assess Symptom and Impacts in Patients With Multiple Myeloma.
Gries KS; Fastenau J; Seo C; Potrata B; Iaconangelo C; Serrano D
Value Health; 2021 Dec; 24(12):1807-1819. PubMed ID: 34838279
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and impacts in anemia of chronic kidney disease.
Mathias SD; Blum SI; Sikirica V; Johansen KL; Colwell HH; Okoro T
J Patient Rep Outcomes; 2020 Jul; 4(1):64. PubMed ID: 32728779
[TBL] [Abstract][Full Text] [Related]
17. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
[TBL] [Abstract][Full Text] [Related]
19. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
[TBL] [Abstract][Full Text] [Related]
20. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
